Maria P. Nikolova

Papers

1

Total Citations

2

H-Index

1

About

Maria P. Nikolova is a leading voice in the safe advancement of nanotechnology, with her research squarely focused on the critical intersection of nanomedicine and nanotoxicology. Her most-cited work, “Challenges in the Assessment of Nanotoxicity, Recommendations, and Safe-by-Design Nanomedicines to Counter Toxicological Problems,” provides a foundational framework for the field. In this highly influential paper, she systematically dissects the complex hurdles in evaluating the safety of engineered nanomaterials—from their unique physicochemical properties to their unpredictable biological interactions. Nikolova’s major contribution lies in championing a “safe-by-design” paradigm, advocating for the proactive integration of toxicological assessment into the earliest stages of nanomaterial development. This forward-thinking approach aims to preemptively mitigate risks, ensuring that revolutionary nanomedicines are not only effective but also inherently safer for clinical use. Her work serves as an essential guide for researchers navigating the promise and peril of nanotechnology, pushing the field toward responsible innovation. By bridging materials science, biology, and toxicology, Nikolova is shaping a future where nanotherapeutics can be deployed with confidence, making her a pivotal figure in the quest for truly translational nanomedicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Challenges in the Assessment of Nanotoxicity, Recommendations, and Safe-by-Design Nanomedicines to Counter Toxicological Problems
2 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 4

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago